# Trade Mark Journal No.2026/005 30 January 2026

## WO0000001895691 (5,10,44)

Office of origin: United States of America

Date of International Registration:2 December 2025
Date of designation in the UK: 2 December 2025

International priority date claimed: 9 June 2025 (United States of America) (99225625)

Class 5
  Diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes and other extra-cellular vesicles for use in disease detection, namely, autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical diagnostic reagents and assays for testing of exosomes and other extra-cellular vesicles in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders.
Class 10
  Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical diagnostic apparatus for detecting autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical diagnostic apparatus, namely, lab-on-a-chip systems comprised of microelectrode arrays and microfluidic controllers, pumps, and valves for use in biological analysis; apparatus for carrying out diagnostic cell-based testing for medical purposes; diagnostic apparatus for autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders, namely, medical diagnostic apparatus for testing cell-derived vesicles or extra-cellular vesicles and detecting autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, reproductive, and viral diseases and disorders; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of oncology; medical diagnostic apparatus for detecting cancer; diagnostic apparatus for cancer diseases, namely, medical diagnostic apparatus for testing cell-derived vesicles or extra-cellular vesicles and detecting cancer.
Class 44
  Medical testing for diagnostic and treatment purposes.

Xzom, Inc.

Representative: Gina L. Durham DLA Piper LLP (US), 555 Mission Street, Suite 2400, San Francisco CA 94105-2933, UNITED STATES OF AMERICA